Calidi Biotherapeutics Income Statement (2021-2025) | CLDI

1Y3Y5Y7Y10YAll
Download Data
Income Statement Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Operating items
Amortization - Intangibles (Quarter) 0.02M0.02M
Depreciation & Amortization - Total (Quarter) 0.10M0.10M0.10M0.10M0.10M0.09M
Research & Development (Quarter) 1.95M2.26M2.62M3.18M3.25M3.96M2.74M2.17M2.15M1.81M2.42M2.59M2.36M2.36M
Selling, General & Administrative (Quarter) 5.04M2.42M2.79M3.36M3.97M5.86M4.01M3.60M3.07M2.21M2.64M3.07M2.69M2.11M
Other Operating Expenses (Quarter) 0.53M0.36M-0.10M-0.10M-0.10M-0.10M-0.10M-0.09M
Operating Expenses (Quarter) 0.53M0.36M6.99M4.69M5.41M6.54M7.22M9.82M6.75M5.77M5.23M4.03M5.06M5.66M5.05M4.47M
Operating Income (Quarter) -0.53M-0.36M-6.99M-4.69M-5.41M-6.54M-7.22M-9.82M-6.75M-5.77M-5.23M-4.03M-5.06M-5.66M-5.05M-4.47M
EBIT (Quarter) -0.53M-0.36M-6.99M-4.69M-5.41M-6.54M-7.22M-9.82M-6.75M-5.77M-5.23M-4.03M-5.06M-5.66M-5.05M-4.47M
Non-operating items
Non Operating Investment Income (Quarter) 0.00M0.03M0.01M
Interest & Investment Income (Quarter) 0.02M0.16M1.09M
Other Non Operating Income (Quarter) 0.00M-0.01M-0.01M-0.02M-0.01M-0.02M-0.02M0.01M0.01M0.01M-0.01M-0.02M0.02M0.12M
Non Operating Income (Quarter) 1.99M4.52M0.00M-0.77M-1.04M-0.02M5.21M1.75M-0.47M0.01M0.16M-0.12M-0.01M-0.09M0.02M0.12M
Net income details
EBT (Quarter) 1.46M4.16M-5.35M-7.76M-6.46M-12.50M-2.01M-8.23M-7.22M-5.76M-5.07M-4.14M-5.06M-5.76M-5.17M-4.06M
Tax Provisions (Quarter) 0.01M0.00M0.00M0.01M-0.00M0.00M0.01M-0.00M0.00M0.00M0.00M0.01M-0.00M
Profit After Tax (Quarter) -7.74M-4.58M-5.36M-7.76M-6.46M-12.50M-2.02M-8.23M-7.22M-5.77M-5.05M-4.08M-5.06M-5.76M-5.15M-4.21M
Income from Non-Controlling Interests (Quarter) -0.01M-0.05M-0.08M-0.05M-0.03M-0.00M
Income from Continuing Operations (Quarter) 1.46M4.16M-5.35M-7.77M-6.46M-12.50M-2.02M-8.23M-7.22M-5.77M-5.07M-4.15M-5.06M-5.76M-5.18M-4.06M
Consolidated Net Income (Quarter) 1.46M4.16M-5.35M-7.77M-6.46M-12.50M-2.02M-8.23M-7.22M-5.77M-5.07M-4.15M-5.06M-5.76M-5.18M-4.06M
Income towards Parent Company (Quarter) 1.46M4.16M-5.35M-7.77M-6.46M-12.50M-2.02M-8.23M-7.22M-5.77M-5.07M-4.15M-5.06M-5.76M-5.18M-4.06M
Net Income towards Common Stockholders (Quarter) 1.46M4.16M-5.35M-7.77M-6.46M-12.50M-2.02M-8.23M-7.22M-7.44M-5.05M-4.10M-4.99M-5.71M-10.82M-4.06M
Additional items
EPS (Basic) (Quarter) 0.050.14-0.635.07-0.75-14.24-1.412.47-2.03-16.75-7.756.70-0.18-1.99-2.210.45
EPS (Weighted Average and Diluted) (Quarter) 0.050.15-0.635.07-0.75-14.24-1.412.47-2.03-16.75-7.756.70-0.18-1.99-2.210.45
Shares Outstanding (Weighted Average) (Quarter) 5.75M5.75M5.75M8.48M8.51M8.65M0.87M1.43M1.69M0.00M444.00652.00667.000.03M0.00M
Shares Outstanding (Diluted Average) (Quarter) 8.89M5.75M5.75M8.48M8.51M8.65M0.88M1.06M1.69M0.00M444.00652.00667.000.03M0.00M0.00M0.00M
EBITDA (Quarter) -0.53M-0.36M-6.99M-4.69M-5.41M-6.54M-7.22M-9.82M-6.75M-5.67M-5.13M-3.93M-5.06M-5.57M-4.94M-4.37M
Interest Expenses (Quarter) 0.03M0.10M0.20M0.21M0.22M-0.25M0.15M0.17M0.10M0.11M0.03M0.03M0.03M0.01M
Tax Rate (Quarter) -0.14%-0.06%-0.03%-0.55%0.04%-0.06%-0.14%0.02%-0.07%-0.06%-0.07%-0.19%0.05%